Invention Grant
- Patent Title: Combination treatments for melanoma
- Patent Title (中): 黑色素瘤的联合治疗
-
Application No.: US14019327Application Date: 2013-09-05
-
Publication No.: US09561245B2Publication Date: 2017-02-07
- Inventor: Sean Morrison , Elena Piskounova , Ugur Eskiocak
- Applicant: The Board of Regents of the University of Texas System
- Applicant Address: US TX Austin
- Assignee: The Board of Regents of the University of Texas System
- Current Assignee: The Board of Regents of the University of Texas System
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K31/585 ; A61K31/506 ; A61K31/437 ; A61K31/404
Abstract:
The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include BRAF inhibitors such as PLX 4720 and PLX 4734 in combination with RO 31-8220, bafetinib or cardiac glycosides.
Public/Granted literature
- US20140066392A1 COMBINATION TREATMENTS FOR MELANOMA Public/Granted day:2014-03-06
Information query
